• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响肛旁瘘管型克罗恩病结局的预后因素:系统综述。

Prognostic factors affecting outcomes in fistulating perianal Crohn's disease: a systematic review.

机构信息

University of Sheffield Medical School, Sheffield, UK.

Department of General Surgery, Northern General Hospital, Herries Road, Sheffield, S5 7AU, UK.

出版信息

Tech Coloproctol. 2017 Jul;21(7):501-519. doi: 10.1007/s10151-017-1647-3. Epub 2017 Jun 20.

DOI:10.1007/s10151-017-1647-3
PMID:28639073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5550543/
Abstract

BACKGROUND

One in three patients with Crohn's disease will develop a perianal fistulae, and one third of these will achieve long-term healing or closure. A barrier to conducting well-designed clinical trials for these patients is a lack of understanding of prognostic factors. This systematic review sets out to identify factors associated with prognosis of perianal Crohn's fistulae.

METHODS

This review was registered on the PROSPERO database (CRD42016050316) and conducted in line with PRISMA guidelines along a predefined protocol. English-language studies assessing baseline factors related to outcomes of fistulae treatment in adult patients were included. Searches were performed on MEDLINE and Embase databases. Screening of abstracts and full texts for eligibility was performed prior to extraction of data into predesigned forms. Bias was assessed using the QUIPS tool.

RESULTS

Searches identified 997 papers. Following removal of duplicates and secondary searches, 923 were screened for inclusion. Forty-seven papers were reviewed at full-text level and 13, 2 of which were randomised trials, were included in the final qualitative review. Two studies reported distribution of Crohn's disease as a prognostic factor for healing. Two studies found that CARD15 mutations decreased response of fistulae to antibiotics. Complexity of fistulae anatomy was implicated in prognosis by 4 studies.

CONCLUSIONS

This systematic review has identified potential prognostic markers, including genetic factors and disease behaviour. We cannot, however, draw robust conclusions from this heterogeneous group of studies; therefore, we recommend that a prospective cohort study of well-characterised patients with Crohn's perianal fistulae is undertaken.

摘要

背景

三分之一的克罗恩病患者会出现肛周瘘,其中三分之一的患者会实现长期愈合或闭合。对这些患者进行精心设计的临床试验的一个障碍是对预后因素缺乏了解。本系统评价旨在确定与肛周克罗恩病瘘预后相关的因素。

方法

本综述在 PROSPERO 数据库(CRD42016050316)上注册,并按照 PRISMA 指南以及预先制定的方案进行。纳入评估成人患者瘘管治疗结局相关基线因素的英语研究。在 MEDLINE 和 Embase 数据库中进行了检索。在将数据提取到预设计表格中之前,对摘要和全文进行了筛选,以确定是否符合纳入标准。使用 QUIPS 工具评估偏倚。

结果

检索共确定了 997 篇论文。在去除重复项和二次检索后,对 923 篇进行了筛选以确定是否纳入。47 篇论文进行了全文审查,其中 13 篇、2 篇为随机试验,被纳入最终的定性综述。有两项研究报告了克罗恩病的分布是愈合的预后因素。有两项研究发现 CARD15 突变降低了瘘对抗生素的反应。四项研究表明瘘管解剖结构的复杂性与预后有关。

结论

本系统评价确定了一些潜在的预后标志物,包括遗传因素和疾病行为。然而,我们不能从这组异质性研究中得出可靠的结论;因此,我们建议对具有明确特征的克罗恩病肛周瘘患者进行前瞻性队列研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159e/5550543/5bdc8d618815/10151_2017_1647_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159e/5550543/dfc5eb9ec0b7/10151_2017_1647_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159e/5550543/5bdc8d618815/10151_2017_1647_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159e/5550543/dfc5eb9ec0b7/10151_2017_1647_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159e/5550543/5bdc8d618815/10151_2017_1647_Fig2_HTML.jpg

相似文献

1
Prognostic factors affecting outcomes in fistulating perianal Crohn's disease: a systematic review.影响肛旁瘘管型克罗恩病结局的预后因素:系统综述。
Tech Coloproctol. 2017 Jul;21(7):501-519. doi: 10.1007/s10151-017-1647-3. Epub 2017 Jun 20.
2
Stem cell transplantation for induction of remission in medically refractory Crohn's disease.干细胞移植治疗药物难治性克罗恩病诱导缓解。
Cochrane Database Syst Rev. 2022 May 13;5(5):CD013070. doi: 10.1002/14651858.CD013070.pub2.
3
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Natalizumab for induction of remission in Crohn's disease.那他珠单抗用于诱导克罗恩病缓解
Cochrane Database Syst Rev. 2006 Jul 19(3):CD006097. doi: 10.1002/14651858.CD006097.
6
Natalizumab for induction of remission in Crohn's disease.那他珠单抗用于诱导克罗恩病缓解
Cochrane Database Syst Rev. 2007 Jan 24(1):CD006097. doi: 10.1002/14651858.CD006097.pub2.
7
Enteral nutritional therapy for inducing remission of Crohn's disease.诱导克罗恩病缓解的肠内营养疗法。
Cochrane Database Syst Rev. 2001(3):CD000542. doi: 10.1002/14651858.CD000542.
8
Low dose naltrexone for induction of remission in Crohn's disease.低剂量纳曲酮诱导克罗恩病缓解
Cochrane Database Syst Rev. 2018 Apr 1;4(4):CD010410. doi: 10.1002/14651858.CD010410.pub3.
9
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
10
Cyclosporine for induction of remission in Crohn's disease.环孢素用于诱导克罗恩病缓解
Cochrane Database Syst Rev. 2005 Apr 18(2):CD000297. doi: 10.1002/14651858.CD000297.pub2.

引用本文的文献

1
Influence of Familial Inflammatory Bowel Disease History on the Use of Immunosuppressants, Biological Agents and Surgery in Patients with Pediatric-Onset of the Disease in the Era of Biological Therapies. Results from the ENEIDA Registry.家族性炎症性肠病病史对生物治疗时代儿童发病的炎症性肠病患者使用免疫抑制剂、生物制剂及手术的影响。来自ENEIDA注册研究的结果
J Clin Med. 2025 May 12;14(10):3352. doi: 10.3390/jcm14103352.
2
Infliximab serum concentrations and disease activity in perianal fistulizing Crohn's disease: a cross-sectional study.英夫利昔单抗血清浓度与肛周瘘管型克罗恩病疾病活动度的关系:一项横断面研究。
Tech Coloproctol. 2024 Jul 20;28(1):86. doi: 10.1007/s10151-024-02953-z.
3

本文引用的文献

1
Association of Coloproctology of Great Britain and Ireland consensus exercise on surgical management of fistulating perianal Crohn's disease.英国和爱尔兰结直肠外科学会关于肛瘘性肛周克罗恩病手术治疗的共识活动
Colorectal Dis. 2017 May;19(5):418-429. doi: 10.1111/codi.13672.
2
Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.宿主遗传学与肠道微生物群在炎症性肠病发病及临床表现中的相互作用
Gut. 2018 Jan;67(1):108-119. doi: 10.1136/gutjnl-2016-312135. Epub 2016 Oct 8.
3
Patient optimization for surgery relating to Crohn's disease.
Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn's disease.
影响英夫利昔单抗治疗克罗恩病肠腔瘘患者疗效的预后因素。
BMC Gastroenterol. 2023 Mar 8;23(1):57. doi: 10.1186/s12876-023-02676-9.
4
The Multidisciplinary Management of Perianal Fistulas in Crohn's Disease: A Systematic Review.克罗恩病肛周瘘管的多学科管理:一项系统评价
Cureus. 2022 Sep 20;14(9):e29347. doi: 10.7759/cureus.29347. eCollection 2022 Sep.
5
Can visceral adipose tissue and skeletal muscle predict recurrence of newly diagnosed Crohn's disease in different treatments.内脏脂肪组织和骨骼肌能否预测不同治疗方案中新诊断克罗恩病的复发。
BMC Gastroenterol. 2022 May 18;22(1):250. doi: 10.1186/s12876-022-02327-5.
6
Management of anoperineal lesions in Crohn's disease: a French National Society of Coloproctology national consensus.克罗恩病肛门直肠病变的处理:法国肛肠学会国家共识。
Tech Coloproctol. 2018 Dec;22(12):905-917. doi: 10.1007/s10151-018-1906-y. Epub 2019 Jan 2.
患者优化与克罗恩病相关的手术。
Nat Rev Gastroenterol Hepatol. 2016 Dec;13(12):707-719. doi: 10.1038/nrgastro.2016.158. Epub 2016 Oct 26.
4
Molecular classification of Crohn's disease reveals two clinically relevant subtypes.克罗恩病的分子分类揭示了两种临床相关亚型。
Gut. 2018 Jan;67(1):36-42. doi: 10.1136/gutjnl-2016-312518. Epub 2016 Oct 14.
5
Smoking is Associated with Higher Disease-related Costs and Lower Health-related Quality of Life in Inflammatory Bowel Disease.吸烟与炎症性肠病中更高的疾病相关成本及更低的健康相关生活质量相关。
J Crohns Colitis. 2017 Mar 1;11(3):342-352. doi: 10.1093/ecco-jcc/jjw160.
6
Surgical management of fistulating perianal Crohn's disease: a UK survey.肛瘘性肛周克罗恩病的外科治疗:一项英国调查。
Colorectal Dis. 2017 Mar;19(3):266-273. doi: 10.1111/codi.13462.
7
Impact of Smoking Cessation on the Clinical Course of Crohn's Disease Under Current Therapeutic Algorithms: A Multicenter Prospective Study.戒烟对当前治疗方案下克罗恩病临床病程的影响:一项多中心前瞻性研究。
Am J Gastroenterol. 2016 Mar;111(3):411-9. doi: 10.1038/ajg.2015.401. Epub 2016 Feb 9.
8
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.克罗恩病和溃疡性结肠炎表型的遗传决定因素:一项基因关联研究。
Lancet. 2016 Jan 9;387(10014):156-67. doi: 10.1016/S0140-6736(15)00465-1. Epub 2015 Oct 18.
9
A think tank of the Italian society of colorectal surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: Crohn's disease.意大利结直肠外科学会(SICCR)的一个智囊团采用德尔菲法对炎症性肠病的外科治疗:克罗恩病
Tech Coloproctol. 2015 Oct;19(10):639-51. doi: 10.1007/s10151-015-1368-4. Epub 2015 Sep 24.
10
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.关联分析确定了38个炎症性肠病的易感基因座,并突出了不同人群间共有的遗传风险。
Nat Genet. 2015 Sep;47(9):979-986. doi: 10.1038/ng.3359. Epub 2015 Jul 20.